Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir Plus Daclatasvir With or Without Ribavirin in HCV GT4
NCT04387526Phase 3Completed
- Sponsor
- Beni Suef University
- Start
- Apr 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of sofosbuvir, daclatasvir in hepatitis C (HCV), sponsored by Beni Suef University. Started Apr 2016; status: completed.
02
Drugs
sofosbuvirdaclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT04387526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04387526.